LambdaVision

Farmington, United States Founded: 2009 • Age: 17 yrs
Protein-based retinal prosthesis for degenerative eye diseases is provided.
Request Access

About LambdaVision

LambdaVision is a company based in Farmington (United States) founded in 2009.. LambdaVision has raised $7.65 million across 10 funding rounds from investors including NASA, HHS and Boryung Pharmaceutical. The company has 7 employees as of December 31, 2021. LambdaVision offers products and services including Protein-based Artificial Retina. LambdaVision operates in a competitive market with competitors including Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others.

  • Headquarter Farmington, United States
  • Employees 7 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lambdavision, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7.65 M (USD)

    in 10 rounds

  • Latest Funding Round
    $7 M (USD), Seed

    Nov 05, 2025

  • Investors
    NASA

    & 8 more

  • Employee Count
    7

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of LambdaVision

LambdaVision offers a comprehensive portfolio of products and services, including Protein-based Artificial Retina. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Restores vision by mimicking photoreceptors in retinal diseases.

People of LambdaVision
Headcount 1-10
Employee Profiles 3
Board Members and Advisors 4
Employee Profiles
People
Nicole L. Wagner
President & CEO
People
Jordan A. Greco
Chief Scientific Officer
People
Jordan Greco, Ph.D.
Chief Scientific Officer

Unlock access to complete

Board Members and Advisors
people
Susan Froshauer
Director
people
Robert R. Birge
Founder
people
Pauline Murphy
Director
people
Kirk Dornbush
Director

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of LambdaVision

LambdaVision has successfully raised a total of $7.65M across 10 strategic funding rounds. The most recent funding activity was a Seed round of $7 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Seed — $7.0M
  • First Round

    (03 Oct 2011)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2025 Amount Seed - LambdaVision Valuation Seven Seven Six
May, 2024 Amount Series A - LambdaVision Valuation Aurelia Foundry
Sep, 2020 Amount Grant - LambdaVision Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in LambdaVision

LambdaVision has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include NASA, HHS and Boryung Pharmaceutical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm investing in tech sectors
Founded Year Domain Location
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by LambdaVision

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - LambdaVision

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lambdavision Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of LambdaVision

LambdaVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for metabolic and orphan diseases are developed by Rezolute.
domain founded_year HQ Location
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
domain founded_year HQ Location
Small molecule therapeutics for ophthalmic disorders are developed.
domain founded_year HQ Location
Therapeutic solutions for diseases are developed using DARPin technology.
domain founded_year HQ Location
mRNA-based therapeutics against cancer and infectious diseases are developed.
domain founded_year HQ Location
Gene therapy solutions for retinal diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about LambdaVision

When was LambdaVision founded?

LambdaVision was founded in 2009 and raised its 1st funding round 2 years after it was founded.

Where is LambdaVision located?

LambdaVision is headquartered in Farmington, United States.

Is LambdaVision a funded company?

LambdaVision is a funded company, having raised a total of $7.65M across 10 funding rounds to date.

How many employees does LambdaVision have?

As of Dec 31, 2021, the latest employee count at LambdaVision is 7.

What does LambdaVision do?

LambdaVision was founded in 2009 in Farmington, United States, within the biotechnology sector focused on medical devices. A protein-based retinal prosthesis is developed by the company to address retinal degenerative diseases such as age-related macular degeneration and retinitis pigmentosa. Photochemical properties of retinylidene proteins are utilized to enable high-resolution vision restoration. Operations center on improving patient quality of life through this innovative approach.

Who are the top competitors of LambdaVision?

LambdaVision's top competitors include EyePoint Pharmaceuticals, Rezolute and Molecular Partners.

What products or services does LambdaVision offer?

LambdaVision offers Protein-based Artificial Retina.

Who are LambdaVision's investors?

LambdaVision has 9 investors. Key investors include NASA, HHS, Boryung Pharmaceutical, E2MC, and Aurelia Foundry.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available